UMBFP insider sale disclosed: 282 shares to be sold on Nasdaq
Rhea-AI Filing Summary
UMB Financial (UMBFP) submitted a Form 144 disclosing a proposed sale of 282 common shares on or about 09/09/2025 on Nasdaq. The shares have an aggregate market value of $34,716.00 and total shares outstanding are reported as 75,928,255. The shares were acquired on 02/12/2023 as restricted stock that vested and were recorded as acquired from UMB Financial. The filer represents compliance with Rule 144 and attests to lacking undisclosed material adverse information.
Positive
- Disclosure compliance: Form 144 filed, specifying broker, number of shares, aggregate value, and planned sale date
- Clear acquisition history: Shares were acquired via restricted stock vesting on 02/12/2023 and source (UMB Financial) is stated
Negative
- None.
Insights
TL;DR: Small, routine insider sale disclosed under Rule 144; immaterial relative to outstanding shares.
The filing reports a proposed sale of 282 shares valued at $34,716 against 75,928,255 shares outstanding, indicating the transaction is de minimis and unlikely to move market sentiment or valuation. The shares were acquired via restricted stock vesting on 02/12/2023, which is consistent with planned post-vesting disposition. Disclosure meets Rule 144 reporting requirements and includes the standard attestation regarding material nonpublic information.
TL;DR: Proper procedural disclosure; transaction appears routine and consistent with equity compensation vesting.
The notice documents the nature of acquisition (restricted stock vest) and identifies the broker and intended exchange (Nasdaq), which reflects transparent compliance with security sale reporting. The representation that the seller is unaware of undisclosed material adverse information aligns with governance best practices for insider dispositions. No related party aggregation or prior three-month sales are reported.